Oncotelic Therapeutics, Inc. Annual Interest Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2023.
  • Oncotelic Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $235K, a 40.5% decline year-over-year.
  • Oncotelic Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $885K, a 71.1% decline year-over-year.
  • Oncotelic Therapeutics, Inc. annual Interest Expense for 2023 was $1.04M, a 64.8% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Interest Expense for 2022 was $2.97M, a 48.3% increase from 2021.
  • Oncotelic Therapeutics, Inc. annual Interest Expense for 2021 was $2M, a 0.23% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.04M -$1.93M -64.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-12
2022 $2.97M +$968K +48.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 $2M +$4.49K +0.23% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
2020 $2M +$1.25M +167% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $749K Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.